Literature DB >> 18212763

Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes.

Derek Leroith1, Domenico Accili.   

Abstract

A wide range of genetically engineered murine models of type 2 diabetes have been created to try to understand the site of the primary defect in insulin action, and the relationship between insulin resistance and impaired beta-cell function in diabetes. Genetic disruption of various aspects known to be important in diabetes has examined specific facets, including glucose sensing, transcription factors for the insulin gene, the insulin gene itself, insulin and insulin-like growth factor receptors, downstream signaling components and some mutations that increase insulin sensitivity. This article focuses on models that have given insight into insulin resistance and impaired insulin production, especially models that examine molecules involved in the signaling pathway downstream of insulin binding its receptor. These models recapitulate many features of human type 2 diabetes and, although they have emphasized the complexity of this disease, they offer numerous opportunities to characterize particular aspects and eventually fit them together to help delineate the human disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212763      PMCID: PMC2714226          DOI: 10.1038/ncpendmet0729

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  69 in total

1.  Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic.

Authors:  Domenico Accili
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

2.  Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction.

Authors:  Michael S Bonkowski; Juliana S Rocha; Michal M Masternak; Khalid A Al Regaiey; Andrzej Bartke
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

3.  Molecular Genetics of Maturity-onset Diabetes of the Young.

Authors: 
Journal:  Trends Endocrinol Metab       Date:  1999-05       Impact factor: 12.015

4.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

5.  The lipid phosphatase SHIP2 controls insulin sensitivity.

Authors:  S Clément; U Krause; F Desmedt; J F Tanti; J Behrends; X Pesesse; T Sasaki; J Penninger; M Doherty; W Malaisse; J E Dumont; Y Le Marchand-Brustel; C Erneux; L Hue; S Schurmans
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

6.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

7.  Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.

Authors:  Eun-Gyoung Hong; Dae Young Jung; Hwi Jin Ko; Zhiyou Zhang; Zhexi Ma; John Y Jun; Jae Hyeong Kim; Andrew D Sumner; Thomas C Vary; Thomas W Gardner; Sarah K Bronson; Jason K Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-10-02       Impact factor: 4.310

8.  Increased islet apoptosis in Pdx1+/- mice.

Authors:  James D Johnson; Noreen T Ahmed; Dan S Luciani; Zhiqiang Han; Hung Tran; Jun Fujita; Stanley Misler; Helena Edlund; Kenneth S Polonsky
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

9.  Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4.

Authors:  E B Katz; A E Stenbit; K Hatton; R DePinho; M J Charron
Journal:  Nature       Date:  1995-09-14       Impact factor: 49.962

10.  beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes.

Authors:  U Ahlgren; J Jonsson; L Jonsson; K Simu; H Edlund
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

View more
  20 in total

Review 1.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

2.  A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.

Authors:  Miki Okada-Iwabu; Toshimasa Yamauchi; Masato Iwabu; Teruki Honma; Ken-ichi Hamagami; Koichi Matsuda; Mamiko Yamaguchi; Hiroaki Tanabe; Tomomi Kimura-Someya; Mikako Shirouzu; Hitomi Ogata; Kumpei Tokuyama; Kohjiro Ueki; Tetsuo Nagano; Akiko Tanaka; Shigeyuki Yokoyama; Takashi Kadowaki
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

3.  Adipsin is an adipokine that improves β cell function in diabetes.

Authors:  James C Lo; Sanda Ljubicic; Barbara Leibiger; Matthias Kern; Ingo B Leibiger; Tilo Moede; Molly E Kelly; Diti Chatterjee Bhowmick; Incoronata Murano; Paul Cohen; Alexander S Banks; Melin J Khandekar; Arne Dietrich; Jeffrey S Flier; Saverio Cinti; Matthias Blüher; Nika N Danial; Per-Olof Berggren; Bruce M Spiegelman
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

4.  Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides.

Authors:  Jiao Luo; Meiling Zheng; Bo Jiang; Chao Li; Shuju Guo; Lijun Wang; Xiangqian Li; Rilei Yu; Dayong Shi
Journal:  Br J Pharmacol       Date:  2020-08-30       Impact factor: 8.739

5.  Disruption of insulin signaling in Myf5-expressing progenitors leads to marked paucity of brown fat but normal muscle development.

Authors:  Matthew D Lynes; Tim J Schulz; Andrew J Pan; Yu-Hua Tseng
Journal:  Endocrinology       Date:  2015-01-27       Impact factor: 4.736

6.  Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways.

Authors:  Yun Chau Long; Zhiyong Cheng; Kyle D Copps; Morris F White
Journal:  Mol Cell Biol       Date:  2010-12-06       Impact factor: 4.272

7.  Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study.

Authors:  Ranjani N Moorthi; Simit Doshi; Linda F Fried; Sharon M Moe; Mark J Sarnak; Suzanne Satterfield; Ann V Schwartz; Michael Shlipak; Brittney S Lange-Maia; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  Nephrol Dial Transplant       Date:  2019-04-01       Impact factor: 5.992

8.  Deletion of Drosophila insulin-like peptides causes growth defects and metabolic abnormalities.

Authors:  Hua Zhang; Jingnan Liu; Caroline R Li; Bahram Momen; Ronald A Kohanski; Leslie Pick
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-03       Impact factor: 11.205

9.  Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2.

Authors:  Anke Assmann; Kohjiro Ueki; Jonathon N Winnay; Takahashi Kadowaki; Rohit N Kulkarni
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

Review 10.  Nutritional systems biology modeling: from molecular mechanisms to physiology.

Authors:  Albert A de Graaf; Andreas P Freidig; Baukje De Roos; Neema Jamshidi; Matthias Heinemann; Johan A C Rullmann; Kevin D Hall; Martin Adiels; Ben van Ommen
Journal:  PLoS Comput Biol       Date:  2009-11-26       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.